To address a potential role of CD27 expression on Tregs in inhibiting anti-tumor immunity, we used a transplantable adenocarcinoma model to challenge mice with a conditional deficiency of CD27 in the Treg compartment. This evidence concerns the gene CD27 and adenocarcinoma.